Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Atomo Diagnostics stock price, quote, forecast and news

AT1.AX
AU0000080327

Price

0.02
Today +/-
+0.00
Today %
+10.00 %
P

Atomo Diagnostics stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Atomo Diagnostics stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Atomo Diagnostics stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Atomo Diagnostics stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Atomo Diagnostics's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Atomo Diagnostics Stock Price History

DateAtomo Diagnostics Price
9/25/20240.02 undefined
9/24/20240.02 undefined
9/23/20240.02 undefined
9/20/20240.02 undefined
9/19/20240.02 undefined
9/18/20240.02 undefined
9/17/20240.02 undefined
9/16/20240.02 undefined
9/13/20240.02 undefined
9/12/20240.02 undefined
9/11/20240.02 undefined
9/10/20240.02 undefined
9/9/20240.02 undefined
9/6/20240.02 undefined
9/5/20240.02 undefined
9/4/20240.02 undefined
9/3/20240.02 undefined
9/2/20240.02 undefined
8/30/20240.02 undefined
8/29/20240.02 undefined
8/28/20240.02 undefined

Atomo Diagnostics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Atomo Diagnostics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Atomo Diagnostics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Atomo Diagnostics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Atomo Diagnostics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Atomo Diagnostics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Atomo Diagnostics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Atomo Diagnostics’s growth potential.

Atomo Diagnostics Revenue, EBIT and net profit per share

DateAtomo Diagnostics RevenueAtomo Diagnostics EBITAtomo Diagnostics Net Income
20244.24 M undefined-5.9 M undefined-6.85 M undefined
20232.54 M undefined-8.88 M undefined-9.96 M undefined
202212.34 M undefined-5.42 M undefined-5.71 M undefined
20216.72 M undefined-5.47 M undefined-6.02 M undefined
20205.37 M undefined-2.74 M undefined-9.22 M undefined
2019539,740 undefined-4.18 M undefined-5.06 M undefined
2018287,250 undefined-6.11 M undefined-4.9 M undefined
2017294,930 undefined-4.78 M undefined-5.15 M undefined

Atomo Diagnostics Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20172018201920202021202220232024
000561224
----20.00100.00-83.33100.00
---60.0050.0033.33-25.00
00033401
-4-6-4-2-5-5-8-5
----40.00-83.33-41.67-400.00-125.00
-5-4-5-9-6-5-9-6
--20.0025.0080.00-33.33-16.6780.00-33.33
560.9560.9560.9561.08564.33568.95570.89634.66
--------
Details

Keystats

ⓘ

Revenue and Growth

The Atomo Diagnostics Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Atomo Diagnostics is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (k)PROVISIONS (M)OTHER SHORT-TERM LIAB. (k)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20172018201920202021202220232024
               
8.281.991.8627.117.9512.976.473.69
0.090.170.3131.860.920.681.23
1.333.531.041.762.631.761.140.83
0.680.260.791.213.043.422.141.84
151.550000000
10.535.96433.0725.4819.0710.437.59
0.470.911.151.513.753.982.741.72
00000000
00000000
0.860.890.91.5233.573.32.07
00000000
00000000
1.341.82.053.036.767.566.043.79
11.877.766.0536.132.2426.6216.4711.38
               
13.2213.1917.1166.5167.9268.0468.0470.09
00000000
-13.16-18.06-22.53-31.58-37.61-43.16-53.25-59.88
-0.01-0.03-0.06-0.45-0.23-0.060-0.12
00000000
0.05-4.89-5.4734.4830.0924.8114.7910.08
337.38459.32604.03930.04654.5378.26179.34478.64
0.460.650.490.461.10.920.890.5
30.146.8128.6764.52304.2776.96256.3125.85
00000000
2.892.773.930.050.070.160.170.08
3.713.885.051.512.131.531.491.19
8.078.726.410.0100.180.080
00000000
32.8543.6458.98105.0223.0792.97104.61106.52
8.118.766.470.110.020.280.190.11
11.8212.6411.521.622.151.811.681.29
11.877.766.0536.132.2426.6216.4711.38
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Atomo Diagnostics provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Atomo Diagnostics's financial health and stability.

Assets

Atomo Diagnostics's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Atomo Diagnostics must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Atomo Diagnostics after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Atomo Diagnostics's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2017201820192020202120222023
0000000
0000000
0000000
0000000
0000000
000-1000
0030111
-5-5-1-6-4-2-5
000-1-5-20
000-1-5-20
0000000
0000000
1005000
50227100
70233000
-------
0000000
-4-11-420-14-9-13
-5.86-6.2-2.65-8.26-10.12-5.11-6.25
0000000

Atomo Diagnostics stock margins

The Atomo Diagnostics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Atomo Diagnostics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Atomo Diagnostics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Atomo Diagnostics's sales revenue. A higher gross margin percentage indicates that the Atomo Diagnostics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Atomo Diagnostics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Atomo Diagnostics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Atomo Diagnostics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Atomo Diagnostics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Atomo Diagnostics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Atomo Diagnostics Margin History

Atomo Diagnostics Gross marginAtomo Diagnostics Profit marginAtomo Diagnostics EBIT marginAtomo Diagnostics Profit margin
202441.48 %-139.08 %-161.56 %
202326.24 %-349.15 %-391.46 %
202234.42 %-43.95 %-46.26 %
202150.91 %-81.48 %-89.66 %
202059.51 %-51.01 %-171.7 %
201917.85 %-774.68 %-936.58 %
201820.66 %-2,126.47 %-1,705.89 %
201715.82 %-1,619.59 %-1,745.67 %

Atomo Diagnostics Stock Sales Revenue, EBIT, Earnings per Share

The Atomo Diagnostics earnings per share therefore indicates how much revenue Atomo Diagnostics has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Atomo Diagnostics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Atomo Diagnostics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Atomo Diagnostics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Atomo Diagnostics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Atomo Diagnostics Revenue, EBIT and net profit per share

DateAtomo Diagnostics Sales per ShareAtomo Diagnostics EBIT per shareAtomo Diagnostics Earnings per Share
20240.01 undefined-0.01 undefined-0.01 undefined
20230 undefined-0.02 undefined-0.02 undefined
20220.02 undefined-0.01 undefined-0.01 undefined
20210.01 undefined-0.01 undefined-0.01 undefined
20200.01 undefined-0 undefined-0.02 undefined
20190 undefined-0.01 undefined-0.01 undefined
20180 undefined-0.01 undefined-0.01 undefined
20170 undefined-0.01 undefined-0.01 undefined

Atomo Diagnostics business model

Atomo Diagnostics is one of the most popular companies on Eulerpool.com.

Atomo Diagnostics Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Atomo Diagnostics historical P/E ratio, EBIT, and P/S ratio.

Atomo Diagnostics shares outstanding

The number of shares was Atomo Diagnostics in 2023 — This indicates how many shares 570.891 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Atomo Diagnostics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Atomo Diagnostics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Atomo Diagnostics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Atomo Diagnostics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Atomo Diagnostics.

Atomo Diagnostics list of shareholders

%
Name
Stocks
Change
Date
4.10280 % Ellerston Capital Limited26,225,164-10,503,5143/20/2023
12.48237 % GZ Family Holdings Pty. Ltd.79,787,53608/8/2023
11.34074 % Kelly (John Michael)72,490,24808/9/2023
10.13941 % LHGP Asset Management 18 Ltd64,811,280012/19/2023
1.79912 % Lin (Xiaoyi)11,500,0002,000,0006/30/2023
1.78204 % Grand Challenges Canada11,390,82406/30/2023
1.71020 % Liverbird Pty. Ltd.10,931,65306/30/2023
1.41305 % I D E Pty. Ltd.9,032,2481,489,4326/30/2023
1.26721 % Australia North Holdings Pty. Ltd.8,100,0001,600,0006/30/2023
1.21874 % Smith (Mark Andrew)7,790,22406/30/2023
1
2
3

Atomo Diagnostics Executives and Management Board

Mr. John Kelly
Atomo Diagnostics Chief Executive Officer, Founder, Managing Director, Director
Compensation 533,091
Mr. John Keith
Atomo Diagnostics Non-Executive Chairman of the Board
Compensation 130,000
Mr. Chandra Sukumar
Atomo Diagnostics Chief Operating Officer
Compensation 72,644
Dr. Paul Kasian
Atomo Diagnostics Non-Executive Director
Compensation 70,000
Ms. Deborah Neff64
Atomo Diagnostics Non-Executive Independent Director
Compensation 53,880
1
2

Atomo Diagnostics Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Viatris Stock
Viatris
SupplierCustomer-0,68-0,87-0,470,840,600,67
1

Most common questions regarding Atomo Diagnostics

What is the P/E ratio of Atomo Diagnostics 2024?

The Atomo Diagnostics P/E ratio is -1.95.

What is the P/S ratio of Atomo Diagnostics 2024?

The Atomo Diagnostics P/S ratio is 3.14.

What is the AlleAktien quality score of Atomo Diagnostics?

The AlleAktien quality score for Atomo Diagnostics is 2/10.

What is the revenue of Atomo Diagnostics 2024?

The Atomo Diagnostics revenue is 4.24 M AUD.

How high is the profit of Atomo Diagnostics 2024?

The Atomo Diagnostics profit is -6.85 M AUD.

What is the business model of Atomo Diagnostics

No history available for Atomo Diagnostics.

What is the Atomo Diagnostics dividend?

Atomo Diagnostics pays a dividend of 0 AUD distributed over payouts per year.

How often does Atomo Diagnostics pay dividends?

The dividend cannot currently be calculated for Atomo Diagnostics or the company does not pay out a dividend.

What is the Atomo Diagnostics ISIN?

The ISIN of Atomo Diagnostics is AU0000080327.

What is the Atomo Diagnostics ticker?

The ticker of Atomo Diagnostics is AT1.AX.

How much dividend does Atomo Diagnostics pay?

Over the past 12 months, Atomo Diagnostics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Atomo Diagnostics is expected to pay a dividend of 0 AUD.

What is the dividend yield of Atomo Diagnostics?

The current dividend yield of Atomo Diagnostics is .

When does Atomo Diagnostics pay dividends?

Atomo Diagnostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Atomo Diagnostics?

Atomo Diagnostics paid dividends every year for the past 0 years.

What is the dividend of Atomo Diagnostics?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Atomo Diagnostics located?

Atomo Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Atomo Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Atomo Diagnostics from 9/26/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.

When did Atomo Diagnostics pay the last dividend?

The last dividend was paid out on 9/26/2024.

What was the dividend of Atomo Diagnostics in the year 2023?

In the year 2023, Atomo Diagnostics distributed 0 AUD as dividends.

In which currency does Atomo Diagnostics pay out the dividend?

The dividends of Atomo Diagnostics are distributed in AUD.

All fundamentals about Atomo Diagnostics

Our stock analysis for Atomo Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Atomo Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.